Serge Leyvraz, MD [clinicaltrials_resource:466b2a788a0b72937bf0ac693f747f33]
Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer [clinicaltrials:NCT00011921]Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma [clinicaltrials:NCT00110123]Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma [clinicaltrials:NCT00324623]
overall official [clinicaltrials_vocabulary:overall-official]
Serge Leyvraz, MD [clinicaltrials_resource:466b2a788a0b72937bf0ac693f747f33]
Bio2RDF identifier
466b2a788a0b72937bf0ac693f747f33
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:466b2a788a0b72937bf0ac693f747f33
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Serge Leyvraz, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:466b2a788a0b72937bf0ac693f747f33
title
Serge Leyvraz, MD
@en
type
label
Serge Leyvraz, MD [clinicaltrials_resource:466b2a788a0b72937bf0ac693f747f33]
@en